Meag Munich Ergo’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Buy |
33,896
+12,372
| +57% | +$3.99M | 0.32% | 69 |
|
|
2025
Q1 | $7.08M | Sell |
21,524
-2,851
| -12% | -$859K | 0.21% | 80 |
|
|
2024
Q4 | $6.71M | Sell |
24,375
-1,055
| -4% | -$336K | 0.21% | 72 |
|
|
2024
Q3 | $8.81M | Sell |
25,430
-917
| -3% | -$316K | 0.28% | 69 |
|
|
2024
Q2 | $8.71M | Buy |
26,347
+10,556
| +67% | +$3.64M | 0.29% | 68 |
|
|
2024
Q1 | $5.74M | Sell |
15,791
-2,282
| -13% | -$751K | 0.21% | 80 |
|
|
2023
Q4 | $5.41M | Sell |
18,073
-16,922
| -48% | -$4.95M | 0.21% | 79 |
|
|
2023
Q3 | $10M | Sell |
34,995
-5,160
| -13% | -$1.47M | 0.44% | 61 |
|
|
2023
Q2 | $11.3M | Buy |
40,155
+3,363
| +9% | +$876K | 0.49% | 62 |
|
|
2023
Q1 | $9.4M | Buy |
36,792
+11,839
| +47% | +$3.45M | 0.44% | 62 |
|
|
2022
Q4 | $8.27M | Buy |
24,953
+8,665
| +53% | +$2.74M | 0.44% | 50 |
|
|
2022
Q3 | $4.52M | Buy |
16,288
+13,073
| +407% | +$3.68M | 0.27% | 67 |
|
|
2022
Q2 | $847K | Buy |
3,215
+2,165
| +206% | +$558K | 0.05% | 154 |
|
|
2022
Q1 | $255K | Hold |
1,050
| – | – | 0.02% | 183 |
|
|
2021
Q4 | $243K | Sell |
1,050
-34,344
| -97% | -$7.3M | 0.02% | 170 |
|
|
2021
Q3 | $7.08M | Sell |
35,394
-4,324
| -11% | -$940K | 1.23% | 20 |
|
|
2021
Q2 | $9.42M | Buy |
39,718
+7,836
| +25% | +$1.96M | 0.9% | 17 |
|
|
2021
Q1 | $7.71M | Buy |
31,882
+18,117
| +132% | +$4.04M | 0.77% | 26 |
|
|
2020
Q4 | $2.81M | Buy |
13,765
+3,862
| +39% | +$757K | 0.65% | 47 |
|
|
2020
Q3 | $1.68M | Buy |
9,903
+251
| +3% | +$44.2K | 0.31% | 81 |
|
|
2020
Q2 | $1.81M | Buy |
9,652
+7,267
| +305% | +$1.38M | 0.34% | 84 |
|
|
2020
Q1 | $423K | Sell |
2,385
-4,193
| -64% | -$813K | 0.1% | 132 |
|
|
2019
Q4 | $1.33M | Sell |
6,578
-18,995
| -74% | -$3.48M | 0.14% | 158 |
|
|
2019
Q3 | $3.81M | Buy |
25,573
+10,149
| +66% | +$1.65M | 0.2% | 118 |
|
|
2019
Q2 | $2.44M | Sell |
15,424
-766
| -5% | -$120K | 0.19% | 115 |
|
|
2019
Q1 | $2.58M | Buy |
16,190
+10,421
| +181% | +$1.9M | 0.21% | 109 |
|
|
2018
Q4 | $1.11M | Sell |
5,769
-28,442
| -83% | -$5.93M | 0.14% | 210 |
|
|
2018
Q3 | $7.02M | Buy |
34,211
+12,372
| +57% | +$2.29M | 0.42% | 71 |
|
|
2018
Q2 | $3.74M | Buy |
21,839
+16,384
| +300% | +$2.84M | 0.23% | 141 |
|
|
2018
Q1 | $914K | Sell |
5,455
-63,359
| -92% | -$12.3M | 0.04% | 325 |
|
|
2017
Q4 | $14.2M | Buy |
68,814
+27,793
| +68% | +$5.53M | 0.55% | 45 |
|
|
2017
Q3 | $7.7M | Buy |
41,021
+15,746
| +62% | +$2.8M | 0.31% | 111 |
|
|
2017
Q2 | $4.21M | Buy |
+25,275
| New | +$4.06M | 0.19% | 155 |
|
|
2017
Q1 | – | Sell |
-22,118
| Closed | -$3.01M | – | 325 |
|
|
2016
Q4 | $3.01M | Buy |
+22,118
| New | +$2.89M | 0.14% | 177 |
|
|
2015
Q3 | – | Sell |
-26,779
| Closed | -$4.37M | – | 233 |
|
|
2015
Q2 | $4.37M | Buy |
+26,779
| New | +$3.7M | 0.22% | 119 |
|
|
2014
Q1 | – | Sell |
-1,153
| Closed | -$100K | – | 209 |
|
|
2013
Q4 | $100K | Buy |
+1,153
| New | +$94.3K | 0.01% | 227 |
|
Other funds holding CI
Meag Munich Ergo's CI Position: Q2 2025 in Review
Meag Munich Ergo increased its Cigna (CI) stake by 57% in Q2 2025, buying an estimated $3.99M and bringing the position to 33,896 shares worth $11.2M. The position accounts for 0.32% of the portfolio, ranked #69.
Meag Munich Ergo first reported a position in CI in Q4 2013 and has held it in 36 quarters since. The position peaked at $14.2M in Q4 2017. 1,733 funds tracked by Wall St. Rank hold CI as of Q2 2025.
- Meag Munich Ergo held 33,896 shares of Cigna worth $11.2M as of Q2 2025.
- Meag Munich Ergo bought 12,372 Cigna shares in Q2 2025, an estimated $3.99M.
- Cigna made up 0.32% of Meag Munich Ergo's portfolio in Q2 2025, its #69 holding.
- Meag Munich Ergo first reported a position in Cigna in Q4 2013 and has held it in 36 quarters since.
- Meag Munich Ergo's Cigna position peaked at $14.2M in Q4 2017.
- 1,733 funds tracked by Wall St. Rank held Cigna as of Q2 2025.
Based on Meag Munich Ergo's 13F filing for Q2 2025, filed 16 Jul 2025.